Ultra Clean Holdings, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. May 23, 2025 Deadline to file Lead Plaintiff Motion

Ultra Clean Holdings, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. May 23, 2025 Deadline to file Lead Plaintiff Motion GlobeNewswire May 19, 2025 Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, May 19, 2025 (GLOBE NEWSWIRE) — The Portnoy Law […]

Fine, Kaplan and Black, R.P.C. Announce Class Action Settlements on Behalf of Those Who Paid and/or Reimbursed for Certain Prescription GENERIC Drugs in the United States between May 1, 2009 and December 31, 2019

LEGAL NOTICE If You Paid or Reimbursed for CertainPRESCRIPTION GENERIC DRUGS in the UnitedStates between May 1, 2009 and December 31, 2019,You Could Get a Payment from twoClass Action Settlements. A federal court authorized this Notice. This is not a solicitation from a lawyer. 1-877-316-0171www.GenericDrugsEndPayerSettlement.com Your legal rights might be affected by two proposed Settlements,

Dorchester Minerals, L.P. Announces Retirement and Appointment to the Board of Managers

(NASDAQ:DMLP), DALLAS, May 19, 2025 (GLOBE NEWSWIRE) — Dorchester Minerals, L.P. (the “Partnership”) (NASDAQ-DMLP). As previously announced, Ron Trout retired as an Independent Manager of the Partnership after the conclusion of his term, which ended immediately following the 2025 Annual Meeting. Casey McManemin, Chairman of the Board, stated “I would like to thank Ron for

Eyenovia Provides Updates on Potential Merger with Betaliq and Development of the Optejet User Filled Device (UFD), and Reports First Quarter 2025 Financial Results

(NASDAQ:EYEN), Eyenovia and Betaliq continue to negotiate a binding merger agreement consistent with the previously announced signed Letter of Intent Reports continued progress on the development of the user-filled Optejet, and remains on track to file for U.S. device regulatory approval in September 2025 Reduced ongoing cash burn by approximately 70% versus prior year and

Dorchester Minerals, L.P. Announces Retirement and Appointment to the Board of Managers

Dorchester Minerals, L.P. Announces Retirement and Appointment to the Board of Managers GlobeNewswire May 19, 2025 DALLAS, May 19, 2025 (GLOBE NEWSWIRE) — Dorchester Minerals, L.P. (the “Partnership”) (NASDAQ-DMLP). As previously announced, Ron Trout retired as an Independent Manager of the Partnership after the conclusion of his term, which ended immediately following the 2025 Annual

Eyenovia Provides Updates on Potential Merger with Betaliq and Development of the Optejet User Filled Device (UFD), and Reports First Quarter 2025 Financial Results

Eyenovia Provides Updates on Potential Merger with Betaliq and Development of the Optejet User Filled Device (UFD), and Reports First Quarter 2025 Financial Results GlobeNewswire May 19, 2025 Eyenovia and Betaliq continue to negotiate a binding merger agreement consistent with the previously announced signed Letter of Intent Reports continued progress on the development of the

CNO Financial Group to Host Virtual Investor Briefing on Tuesday, June 10

CNO Financial Group, Inc. (NYSE: CNO) today announced that it will host a virtual investor briefing focused on its Investments function on Tuesday, June 10, 2025 from 9:00 a.m. to approximately 10:00 a.m. Eastern Time. The presenters will include members of CNO's investment management team. https://mma.prnewswire.com/media/1014781/CNO_Financial_Group_Logo.jpg This event will provide investors, analysts and key stakeholders

Qualigen Therapeutics, Inc. receives expected notification of deficiency from Nasdaq related to delayed filing of quarterly report on Form 10-Q

(NASDAQ:QLGN), CARLSBAD, Calif., May 19, 2025 (GLOBE NEWSWIRE) — Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (the “Company”) announced today that it received an expected deficiency notification letter from the Listing Qualifications Staff of The Nasdaq Stock Market LLC (“Nasdaq”) on May 19, 2025 (the “Notice”). The Notice indicated that the Nasdaq Hearings Panel (the “Panel”) will

Qualigen Therapeutics, Inc. receives expected notification of deficiency from Nasdaq related to delayed filing of quarterly report on Form 10-Q

Qualigen Therapeutics, Inc. receives expected notification of deficiency from Nasdaq related to delayed filing of quarterly report on Form 10-Q GlobeNewswire May 19, 2025 CARLSBAD, Calif., May 19, 2025 (GLOBE NEWSWIRE) — Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (the “Company”) announced today that it received an expected deficiency notification letter from the Listing Qualifications Staff of

Tortuga Bay Puntacana Nominated for Condé Nast Traveler Readers’ Choice Awards 2025

Tortuga Bay Puntacana is proud to announce its nomination in the prestigious Condé Nast Traveler Readers' Choice Awards 2025, one of the most respected accolades in the luxury travel industry. This nomination recognizes their commitment to excellence, personalized service, and its unique blend of Caribbean charm and refined sophistication. Designed by legendary fashion icon Oscar

Scroll to Top